These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 18309962)
41. Osteoid lesions of the extremities. Mandell GA; Harcke HT; Kumar SJ Top Magn Reson Imaging; 1991 Dec; 4(1):66-76. PubMed ID: 1764259 [No Abstract] [Full Text] [Related]
42. [Diagnostic imaging in bone metastasis from prostate cancer]. Arisaka Y; Nakazawa A; Endo K Nihon Rinsho; 2011 Jun; 69 Suppl 5():285-90. PubMed ID: 22207987 [No Abstract] [Full Text] [Related]
43. The role of whole body bone scan in bronchogenic carcinoma. Kim K; Kim KR; Sohn HY; Lee UY; Kim SK; Lee WY Yonsei Med J; 1984; 25(1):11-7. PubMed ID: 6336206 [No Abstract] [Full Text] [Related]
44. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Savelli G; Maffioli L; Maccauro M; De Deckere E; Bombardieri E Q J Nucl Med; 2001 Mar; 45(1):27-37. PubMed ID: 11456373 [TBL] [Abstract][Full Text] [Related]
45. [Guidelines for bone scintigraphy]. Bares R Nuklearmedizin; 1999; 38(6A):251-3. PubMed ID: 10510823 [No Abstract] [Full Text] [Related]
46. [Efficacy of bone imaging in detecting the osseous metastasis of prostatic carcinoma]. Miki M Rinsho Hoshasen; 1983 May; 28(5):585-7. PubMed ID: 6887614 [No Abstract] [Full Text] [Related]
47. Diffusion-weighted MR imaging: adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases? Lecouvet FE; Vande Berg BC; Malghem J; Omoumi P; Simoni P Radiology; 2009 Aug; 252(2):624. PubMed ID: 19703896 [No Abstract] [Full Text] [Related]
48. Editorial comment on: Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Weckermann D Eur Urol; 2007 Jul; 52(1):132-3. PubMed ID: 17258388 [No Abstract] [Full Text] [Related]
49. The staging of M1 disease: the role of bone scan, Xray and other imaging techniques. Richards B; Bollack C; Bouffioux C Prog Clin Biol Res; 1988; 269():233-42. PubMed ID: 3293062 [TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and treatment of metastatic bone cancer]. Tateishi A Gan To Kagaku Ryoho; 1996 Sep; 23(10):1262-8. PubMed ID: 8831737 [TBL] [Abstract][Full Text] [Related]
51. [NMR tomography in plasmacytoma]. Linden A; Gückel C; Widder R; Jungehülsing M; Diehl V; Schicha H Rofo; 1992 Jan; 156(1):83-8. PubMed ID: 1733480 [TBL] [Abstract][Full Text] [Related]
52. Imaging in bone cancer. Edeiken J; Karasick D CA Cancer J Clin; 1987; 37(4):239-45. PubMed ID: 3111652 [No Abstract] [Full Text] [Related]
54. [Lumbar pain and bone gammagraphy]. Setoain J; Solá M Med Clin (Barc); 1996 Feb; 106(5):180-1. PubMed ID: 8684017 [No Abstract] [Full Text] [Related]
55. The role of SPECT/CT in skeletal malignancies. Ghosh P Semin Musculoskelet Radiol; 2014 Apr; 18(2):175-93. PubMed ID: 24715449 [TBL] [Abstract][Full Text] [Related]
56. Trapped by an incidental finding. Pauker SG; Kopelman RI N Engl J Med; 1992 Jan; 326(1):40-3. PubMed ID: 1370063 [No Abstract] [Full Text] [Related]
57. The "super" bone scan. Higginbotham EA J Natl Med Assoc; 1980 Mar; 72(3):291-4. PubMed ID: 7392072 [No Abstract] [Full Text] [Related]
58. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. Even-Sapir E J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595 [TBL] [Abstract][Full Text] [Related]
59. Clinical radionuclide bone imaging. Holder LE Radiology; 1990 Sep; 176(3):607-14. PubMed ID: 2202009 [No Abstract] [Full Text] [Related]
60. MRI and the detection of bone marrow tumor. Cohen MD AJR Am J Roentgenol; 2008 Jan; 190(1):W75. PubMed ID: 18094278 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]